Urinary biomarkers and progression of AKI in patients with cirrhosis

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 11, 2015, Pages 1857-1867

  Belcher, Justin M ^a,b,d   Garcia Tsao, Guadalupe ^c,d   Sanyal, Arun J ^e   Thiessen Philbrook, Heather ^f   Peixoto, Aldo J ^b,d   Perazella, Mark A ^b,d   Ansari, Naheed ^g   Lim, Joseph ^c   Coca, Steven G ^a,b,d   Parikh, Chirag R ^a,b,d  

^a Sections of Nephrology ^*  (United States)

^b Section of Nephrology   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g JACOBI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALBUMINURIA; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SODIUM EXCRETION;

EID: 84925944828     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09430913/-/DCSupplemental     Document Type: Article

References (32)

1. Arabi Y, Ahmed QA, Haddad S, Aljumah A, Al-Shimemeri A: Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol 16: 333–339, 2004.
2. Cárdenas A, Ginés P, Uriz J, Bessa X, Salmerón JM, Mas A, Ortega R, Calahorra B, De Las Heras D, Bosch J, Arroyo V, Rodés J: Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34: 671–676, 2001.
3. Tandon P, Garcia-Tsao G: Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol 9: 260–265, 2011.
4. Belcher JM, Garcia-Tsao G, Sanyal AJ, Bhogal H, Lim JK, Ansari N, Coca SG, Parikh CR; TRIBE-AKI Consortium: Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 57: 753–762, 2013.
5. Jenq CC, Tsai MH, Tian YC, Lin CY, Yang C, Liu NJ, Lien JM, Chen YC, Fang JT, Chen PC, Yang CW: RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 33: 1921–1930, 2007.
6. Cholongitas E, Calvaruso V, Senzolo M, Patch D, Shaw S, O’Beirne J, Burroughs AK: RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepatol 24: 1639–1647, 2009.
7. de Carvalho JR, Villela-Nogueira CA, Luiz RR, Guzzo PL, da Silva Rosa JM, Rocha E, Moraes Coelho HS, de Mello Perez R: Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites. J Clin Gastroenterol 46: e21– e26, 2012.
8. du Cheyron D, Bouchet B, Parienti JJ, Ramakers M, Charbonneau P: The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 31: 1693–1699, 2005.
9. Dobre M, Demirjian S, Sehgal AR, Navaneethan SD: Terlipressin in hepatorenal syndrome: A systematic reviewand meta-analysis. Int Urol Nephrol 43: 175–184, 2011.
10. Appenrodt B, Zielinski J, Brensing KA, Heller J, Sauerbruch T, Schepke M: Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: A retrospective analysis. Eur J Gastroenterol Hepatol 21: 1428– 1432, 2009.
11. Colle I, Durand F, Pessione F, Rassiat E, Bernuau J, Barriére E, Lebrec D, Valla DC, Moreau R: Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: A retrospective analysis. J Gastroenterol Hepatol 17: 882–888, 2002.
12. Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH: Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl 16: 440–446, 2010.
13. Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS: Simultaneous liver-kidney transplantation summit: Current state and future directions. Am J Transplant 12: 2901–2908, 2012.
14. Francoz C, Prié D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, Valla D, Durand F: Inaccuracies of creatinine and creatininebased equations in candidates for liver transplantation with low creatinine: Impact on the model for end-stage liver disease score. Liver Transpl 16: 1169–1177, 2010.
15. Koyner JL, Garg AX, Coca SG, Sint K, Thiessen-Philbrook H, Patel UD, Shlipak MG, Parikh CR; TRIBE-AKI Consortium: Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 23: 905–914, 2012.
16. Siew ED, Ikizler TA, Gebretsadik T, Shintani A, Wickersham N, Bossert F, Peterson JF, Parikh CR, May AK, Ware LB: Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol 5: 1497–1505, 2010.
17. Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, Han WK, Marcus RJ, Parikh CR: IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J AmSoc Nephrol 21: 189–197, 2010.
18. Wagener G, Minhaz M, Mattis FA, Kim M, Emond JC, Lee HT: Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant 26: 1717–1723, 2011.
19. Portal AJ, McPhail MJ, Bruce M, Coltart I, Slack A, Sherwood R, Heaton ND, Shawcross D, Wendon JA, Heneghan MA: Neutrophil gelatinase—associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transpl 16: 1257–1266, 2010.
20. Fagundes C, Pépin MN, Guevara M, Barreto R, Casals G, Solá E, Pereira G, Rodráguez E, Garcia E, Prado V, Poch E, Jiménez W, Fernández J, Arroyo V, Ginés P: Urinaryneutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol 57: 267–273, 2012.
21. Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola- Del Valle DA, Adkins SH, Sise ME, Oliver JA, Radhakrishnan J, Barasch JM, Nickolas TL: Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci 57: 2362–2370, 2012.
22. Slack AJ, McPhail MJ, Ostermann M, Bruce M, Sherwood R, Musto R, Dew T, Auzinger G, Bernal W, O’Grady J, Heneghan MA, Moore K, Wendon JA: Predicting the development of acute kidney injury in liver cirrhosis—an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. Aliment Pharmacol Ther 37: 989–997, 2013.
23. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231–1238, 2005.
24. Shibata M, Hirota M, Nozawa F, Okabe A, Kurimoto M, Ogawa M: Increased concentrations of plasma IL-18 in patients with hepatic dysfunction after hepatectomy. Cytokine 12: 1526– 1530, 2000.
25. Parikh CR, Thiessen Philbrook H, Garg AX, Kadiyala D, Shlipak MG, Koyner JL, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Coca SG; TRIBE-AKI Consortium: Performance of kidney injury molecule-1 and liver fatty acid binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 8: 1079–1088, 2013.
26. Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V: Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 60: 702–709, 2011.
27. Siew ED, Matheny ME, Ikizler TA, Lewis JB, Miller RA, Waitman LR, Go AS, Parikh CR, Peterson JF: Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 77: 536–542, 2010.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461–470, 1999.
29. Salerno F, Gerbes A, Ginés P, Wong F, Arroyo V: Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56: 1310–1318, 2007.
30. Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P; Terlipressin Study Group: Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serumcreatinine to hemodynamics. JHepatol 55: 315–321, 2011.
31. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH: Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 16: 49–54, 2010.
32. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR: The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: Amulticenter pooled analysis of prospective studies. J Am Coll Cardiol 57: 1752–1761, 2011.